Takeda drops pioglitazone/metformin extended release combo in the EU
This article was originally published in Scrip
Executive Summary
Takeda has withdrawn an EU marketing authorisation application for an extended release version of its oral antidiabetic product Competact, and has decided to discontinue the further development in the EU of this form of the fixed dose combination.